rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

Curis, Inc.

CRIS · Nasdaq

Health CareBiotechnologyNot moving yet

CRIS stood above a rising 150-day average in 0 of the last 52 weekly readings. It is 94.2% below that average now. Biotechnology: 16% of its 561 stocks in an uptrend (−15 points in four weeks); Health Care: 26% (−10 points in four weeks).

Statistics

Rotation
Not moving yet
Weeks in an uptrend
out for 52
Industry in uptrend
16% -15 in 4 wk
Insider buys, 12 months
$11K
Insider sales, 12 months
$0
Officials’ trades on record
0
Institutions holding
41 (-8)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 0 of 52 weeks.

20 Apr – 19 Oct
17%28%39%Apr 26Jun 26Jul 26Sep 26Oct 26

Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026
$0$11KNov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months1
Sale orders, 12 months0
Buyers · sellers1 · 0
WhoDidSharesTraded
Kenneth I. KaitinDirectorbought10,000at $0.548731 Mar 2026filed 1 Apr 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders41-8 on the quarter
New · exited7 · 14
Reported value$7.5M

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

ManagerSharesChange
Stonepine Capital Management, LLCadded · filed 14 Aug 202614,312,187$3.2M+10,585,781+284.1%
Bleichroeder LPunchanged · filed 13 Aug 20263,802,329$2.0M00.0%
Cable Car Capital, LPunchanged · filed 14 Aug 20261,333,334$696K00.0%
CM Management, LLCadded · filed 13 Aug 2026550,000$287K+400,000+266.7%
MORGAN STANLEYadded · filed 13 Aug 2026511,792$275K+251,047+96.3%
VANGUARD CAPITAL MANAGEMENT LLCreduced · filed 13 Aug 2026374,941$228K-30,484−7.5%
GEODE CAPITAL MANAGEMENT, LLCadded · filed 12 Aug 2026319,508$194K+126,362+65.4%
M28 Capital Management LPunchanged · filed 13 Aug 2026284,889$149K00.0%
FLPUTNAM INVESTMENT MANAGEMENT COnew · filed 6 Aug 2026245,750$128K+245,750
RENAISSANCE TECHNOLOGIES LLCreduced · filed 13 Aug 2026141,972$74K-224,768−61.3%
31 Mar 2023 – 30 Jun 2026
32547Mar 23Dec 23Dec 24Sep 25Jun 26

News

No headline names it lately.

Everyone who traded it

Anne Elizabeth Borgman Company insiderDirector · last 7 Jul 20260 · 0
Diantha Duvall Company insiderCFO · last 7 Jul 20260 · 0
James E. Dentzer Company insiderPresident & CEO · last 7 Jul 20260 · 8
John Hohneker Company insiderDirector · last 7 Jul 20260 · 0
Jonathan B. Zung Company insiderCDO · last 7 Jul 20260 · 0
Kenneth I. Kaitin Company insiderDirector · last 7 Jul 20262 · 2
Marc Rubin Company insiderDirector · last 7 Jul 20262 · 1
Martyn D. Greenacre Company insiderDirector · last 7 Jul 20260 · 5
Ahmed Hamdy Company insiderCMO · last 20 Mar 20260 · 0
Robert Martell Company insiderHead of Research & Development · last 20 Jan 20230 · 1
Lori Anne Kunkel Company insiderDirector · last 31 Jan 20220 · 1
William Steinkrauss Company insiderChief Financial Officer · last 29 Jan 20220 · 0

Same industry

MRNA ModernaLeading+154%
ENTX Entera BioLeading+49%
XNCR XencorLeading+32%

Distance from each stock’s own 150-day average.

Government contracts

No federal award is tied to it.

From its SEC filings

Operating profit marginFY 2025 · to 31 Dec 2025-60.5%
Return on capital employedFY 2025 · to 31 Dec 2025-97.0%
Share count trendFY 2025 · to 20 Mar 2026209%
Cash and equivalentsFY 2025 · to 31 Dec 2025$5.1M

Analyst forecasts

No analyst forecasts yet.